Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
3.490
-0.060 (-1.69%)
At close: Feb 27, 2026, 4:00 PM EST
3.470
-0.020 (-0.57%)
After-hours: Feb 27, 2026, 7:43 PM EST
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $593.09 million as of February 27, 2026. Its market cap has increased by 115.94% in one year.
Market Cap
593.09M
Enterprise Value
441.65M
1-Year Change
115.94%
Ranking
Category
Stock Price
$3.49
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $593.09M, a decrease of -77.04%. That is a compound annual growth rate of -45.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 593.09M | 94.97% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 631.47M |
| Lexicon Pharmaceuticals | 619.27M |
| Zura Bio | 607.79M |
| LB Pharmaceuticals | 606.93M |
| Ocugen | 606.63M |
| MeiraGTx Holdings | 603.68M |
| Allogene Therapeutics | 601.15M |
| Design Therapeutics | 598.69M |